Spears Kelvin 4

What Happened

• Kelvin Spears, a director of Nutex Health, had 183 restricted stock units (RSUs convert 1:1 to common stock) vest and convert into shares on March 10, 2026. Of those, 82 shares were sold to cover tax withholding at $86.22 per share for total proceeds of $7,070. The filing also reports 116 RSUs (a derivative award), which the footnotes show were granted and will vest in three equal installments on March 1, 2027, 2028 and 2029.
• This activity is largely routine compensation-related action (vesting and a sell-to-cover for taxes), not a market-timed purchase or investment sale by the insider.

Key Details

• Transaction dates and types: March 10, 2026 — 183 RSUs vested/converted (code M); March 10, 2026 — 82 shares sold for tax withholding at $86.22/share (code F); 116 RSUs reported as derivative (code M) and, per footnote, granted 3/11/2026 with multi-year vesting.
• Proceeds: 82 shares sold × $86.22 = $7,070.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes of note:
  • F1: RSUs convert into common stock on a one-for-one basis.
  • F2: Of the 183 shares issued after vesting, 82 were sold to cover tax withholding.
  • F3: The 116 RSUs were granted (per footnote) and vest in three equal installments on 3/1/2027, 3/1/2028 and 3/1/2029.
• Filing timeliness: Report filed March 11, 2026; transaction dates in the filing are March 10, 2026 — filing appears timely under normal Form 4 rules.

Context

• The sale of 82 shares was a sell-to-cover for tax withholding tied to RSU vesting, a common and administrative action that does not necessarily indicate the insider’s view on the company’s stock.
• The primary “acquisitions” were RSU conversions and the grant of new RSUs that vest over future years — these are compensation awards rather than open-market purchases.